000 01796 a2200421 4500
005 20250515173021.0
264 0 _c20100212
008 201002s 0 0 eng d
022 _a1555-8576
024 7 _a10.4161/cbt.8.14.8880
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetrella, Brenda L
245 0 0 _aPTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
_h[electronic resource]
260 _bCancer biology & therapy
_cJul 2009
300 _a1389-401 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBasic Helix-Loop-Helix Transcription Factors
_xbiosynthesis
650 0 4 _aCarcinoma, Renal Cell
_xgenetics
650 0 4 _aCell Line, Tumor
_xmetabolism
650 0 4 _aCell Transformation, Neoplastic
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xphysiology
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aMatrix Metalloproteinase 14
_xbiosynthesis
650 0 4 _aNeoplasm Proteins
_xbiosynthesis
650 0 4 _aPTEN Phosphohydrolase
_xphysiology
650 0 4 _aPhosphatidylinositol 3-Kinases
_xphysiology
650 0 4 _aProtein Serine-Threonine Kinases
_xphysiology
650 0 4 _aProto-Oncogene Proteins c-akt
_xphysiology
650 0 4 _aSignal Transduction
_xgenetics
650 0 4 _aTOR Serine-Threonine Kinases
650 0 4 _aVon Hippel-Lindau Tumor Suppressor Protein
_xgenetics
650 0 4 _aYY1 Transcription Factor
_xantagonists & inhibitors
700 1 _aBrinckerhoff, Constance E
773 0 _tCancer biology & therapy
_gvol. 8
_gno. 14
_gp. 1389-401
856 4 0 _uhttps://doi.org/10.4161/cbt.8.14.8880
_zAvailable from publisher's website
999 _c18908424
_d18908424